Accounts Receivable, after Allowance for Credit Loss, Current in USD of Baird Medical Investment Holdings Ltd from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Baird Medical Investment Holdings Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2023 to Q2 2025.
  • Baird Medical Investment Holdings Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2025 was $40.8M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Baird Medical Investment Holdings Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $40.8M Jun 30, 2025 6-K 2025-12-05
Q4 2024 $46.6M +$15.5M +49.8% Dec 31, 2024 6-K 2025-12-05
Q4 2023 $31.1M Dec 31, 2023 20-F 2025-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.